Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
JAMA Network Open
|
October 2, 2025
Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations
Micah Ostrowski, Yeonjung Jo, Chadi Hage Chehade, et al.
The Lancet. Oncology
|
June 11, 2022
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Neeraj Agarwal, Bradley McGregor, Benjamin L Maughan, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)
Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2021
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma
Zeynep B Zengin, Caroline Weipert, Nicholas J Salgia, et al.
Ophthalmology
|
February 22, 2025
Corrigendum
Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, et al.
The Prostate
|
April 1, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting
Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, et al.
Ophthalmology
|
June 7, 2024
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study
Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
Clinical Proteomics
|
April 18, 2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Hyejung Lee, Jincheng Shen, Muhammad Zaki Fadlullah, et al.
The Oncologist
|
August 29, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
JAMA Network Open
|
October 2, 2025
Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations
Micah Ostrowski, Yeonjung Jo, Chadi Hage Chehade, et al.
The Lancet. Oncology
|
June 11, 2022
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)
Neeraj Agarwal, Bradley McGregor, Benjamin L Maughan, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)
Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2021
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma
Zeynep B Zengin, Caroline Weipert, Nicholas J Salgia, et al.
Ophthalmology
|
February 22, 2025
Corrigendum
Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, et al.
The Prostate
|
April 1, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting
Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, et al.
Ophthalmology
|
June 7, 2024
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study
Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
Clinical Proteomics
|
April 18, 2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Hyejung Lee, Jincheng Shen, Muhammad Zaki Fadlullah, et al.
The Oncologist
|
August 29, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
Raquel Zimmerman, Mehmet A Bilen, Elisabeth I Heath, et al.
Page
of 12